Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism.
Combination treatment with low-dose thiopurine and allopurinol (AP) has successfully been used in patients with inflammatory bowel disease with a so called skewed thiopurine metabolite profile. In red blood cells in vivo, it reduces the concentration of methylated metabolites and increases the conce...
Main Authors: | Sofie Haglund, Svante Vikingsson, Sven Almer, Jan Söderman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5344510?pdf=render |
Similar Items
-
Ultrastructural Features of Gold Nanoparticles Interaction with HepG2 and HEK293 Cells in Monolayer and Spheroids
by: Boris Chelobanov, et al.
Published: (2020-10-01) -
Mercaptopurine and inflammatory bowel disease: the other thiopurine
by: Fernando Bermejo, et al. -
Gene expression and thiopurine metabolite profiling in inflammatory bowel disease - novel clues to drug targets and disease mechanisms?
by: Sofie Haglund, et al.
Published: (2013-01-01) -
Development of new methodology for therapeutic drug monitoringof thiopurine treatment
by: Vikingsson, Svante
Published: (2012) -
Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD
by: Brigitte Moreau, et al.
Published: (2017-11-01)